Armstrong Henry H Associates Inc Amgen Inc Transaction History

Armstrong Henry H Associates Inc

$1.04 Billion
Q3 2024

A detailed history of Armstrong Henry H Associates Inc transactions in Amgen Inc stock. As of the latest transaction made, Armstrong Henry H Associates Inc holds 1,106 shares of AMGN stock, worth $312,854. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,106

Previous 1,106 -0.0%

Holding current value

$312,854

Previous $345,000 3.19%

% of portfolio

0.03%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	BUY	$268.87 - $324.56 $63,184 - $76,271	235 Added 26.98%	1,106 $314,000
Q4 2023 Jan 10, 2024	BUY	$255.7 - $288.46 $255 - $288	1 Added 0.11%	871 $250,000
Q3 2023 Oct 16, 2023	BUY	$218.65 - $271.46 $190,225 - $236,170	870 New	870 $233,000
Q4 2022 Jan 09, 2023	BUY	$229.03 - $291.01 $199,485 - $253,469	871 New	871 $229,000
Q1 2022 Apr 27, 2022	SELL	$219.27 - $242.57 $151,296 - $167,373	-690 Reduced 43.51%	896 $217,000
Q4 2021 Jan 20, 2022	BUY	$198.88 - $227.6 $14,717 - $16,842	74 Added 4.89%	1,586 $357,000
Q2 2021 Jul 20, 2021	SELL	$233.58 - $259.14 $11,679 - $12,957	-50 Reduced 3.2%	1,512 $369,000
Q4 2020 Feb 01, 2021	SELL	$216.38 - $257.67 $276,750 - $329,559	-1,279 Reduced 45.02%	1,562 $359,000
Q4 2019 Jan 29, 2020	SELL	$189.21 - $243.2 $24,597 - $31,616	-130 Reduced 4.38%	2,841 $685,000
Q1 2018 Apr 30, 2018	SELL	$169.43 - $198.0 $37,613 - $43,956	-222 Reduced 6.95%	2,971 $520,000
Q4 2017 Jan 23, 2018	SELL	$168.79 - $188.59 $9,283 - $10,372	-55 Reduced 1.69%	3,193 $555,000
Q3 2017 Oct 24, 2017	BUY	$167.29 - $191.0 $543,357 - $620,368	3,248	3,248 $606,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armstrong Henry H Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Armstrong Henry H Associates Inc with notifications on news.

Account

Armstrong Henry H Associates Inc Amgen Inc Transaction History